The Pfizer-BioNTech vaccine appears to have a high degree of efficacy against the more transmissible variants of the coronavirus first identified in the United Kingdom and Brazil.

The study in question could ease fears that the new strains of the virus would result in another surge in the United States.

Recommended Stories

Pfizer testing third dose of vaccine to protect against coronavirus variants

For the vaccinated, risks of delta variant are small

UK coronavirus variant may have been spreading sooner in the US than previously thought: CDC study